GlaxoSmithKline plc (LON:GSK) announced a dividend on Wednesday, May 1st, Upcoming.Co.Uk reports. Shareholders of record on Thursday, May 16th will be paid a dividend of GBX 19 ($0.25) per share on Thursday, July 11th. This represents a yield of 1.22%. The ex-dividend date of this dividend is Thursday, May 16th. The official announcement can be viewed at this link.
LON:GSK traded up GBX 10.40 ($0.14) on Friday, reaching GBX 1,582 ($20.67). 6,291,966 shares of the company’s stock were exchanged, compared to its average volume of 9,120,000. The company has a debt-to-equity ratio of 942.07, a current ratio of 0.72 and a quick ratio of 0.45. The firm has a market capitalization of $78.26 billion and a PE ratio of 20.15. GlaxoSmithKline has a 52-week low of GBX 1,408.80 ($18.41) and a 52-week high of GBX 1,648.80 ($21.54).
GSK has been the topic of a number of recent research reports. Barclays restated an “equal weight” rating on shares of GlaxoSmithKline in a research note on Wednesday, April 10th. Credit Suisse Group set a GBX 1,600 ($20.91) target price on shares of GlaxoSmithKline and gave the stock a “neutral” rating in a research note on Wednesday, April 10th. Shore Capital restated a “hold” rating on shares of GlaxoSmithKline in a research note on Thursday, May 2nd. UBS Group restated a “neutral” rating and set a GBX 1,630 ($21.30) target price on shares of GlaxoSmithKline in a research note on Thursday, May 2nd. Finally, Jefferies Financial Group restated a “buy” rating on shares of GlaxoSmithKline in a research note on Friday. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of GBX 1,526.14 ($19.94).
In other news, insider Manvinder Singh Banga acquired 458 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The stock was acquired at an average cost of GBX 1,568 ($20.49) per share, with a total value of £7,181.44 ($9,383.82).
TRADEMARK VIOLATION NOTICE: This article was originally published by Sundance Herald and is owned by of Sundance Herald. If you are viewing this article on another domain, it was copied illegally and republished in violation of international trademark & copyright legislation. The original version of this article can be accessed at https://sundanceherald.com/2019/05/24/glaxosmithkline-plc-gsk-plans-gbx-19-dividend.html.
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.
Featured Article: Penny Stocks, Risk and Reward Factors
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.